Clinical trial
Assessing the Safety of Inhaled Zanamivir Exposure in Pregnant Women
NCT01462487 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Safety of Inhaled Zanamivir Exposure in Pregnant Women
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- August 31, 2012
- Enrollment
- 1 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.